HCM
Price:
$18.38
Market Cap:
$3.20B
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for CRC, breast cancer, GC, endometrial cancer (EMC), NSCLC, hepatocellular carcinoma, and gastrointestinal and solid tumors. It also develops Surufatinib, an inhibitor for neuroendocrine tumors (NET), pancreatic NET, non-pancreatic NET, biliary tract ca...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2016-03-16
Stock Exchange
NASDAQ
Ticker
HCM
According to HUTCHMED (China) Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 3.08B. This represents a change of -79.02% compared to the average of 14.69B of the last 4 quarters.
The mean historical Enterprise Value of HUTCHMED (China) Limited over the last ten years is 15.68B. The current 3.08B Enterprise Value has changed 1.87% with respect to the historical average. Over the past ten years (40 quarters), HCM's Enterprise Value was at its highest in in the September 2021 quarter at 30.90B. The Enterprise Value was at its lowest in in the September 2014 quarter at 0.
Average
15.68B
Median
15.23B
Minimum
7.10B
Maximum
27.46B
Discovering the peaks and valleys of HUTCHMED (China) Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 213.88%
Maximum Annual Enterprise Value = 27.46B
Minimum Annual Increase = -55.47%
Minimum Annual Enterprise Value = 7.10B
Year | Enterprise Value | Change |
---|---|---|
2023 | 15.19B | 24.19% |
2022 | 12.23B | -55.47% |
2021 | 27.46B | 24.00% |
2020 | 22.15B | 33.42% |
2019 | 16.60B | 8.65% |
2018 | 15.28B | -39.69% |
2017 | 25.33B | 213.88% |
2016 | 8.07B | 9.11% |
2015 | 7.40B | 4.21% |
2014 | 7.10B | 0.95% |
The current Enterprise Value of HUTCHMED (China) Limited (HCM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
18.29B
5-year avg
18.73B
10-year avg
15.68B
HUTCHMED (China) Limited’s Enterprise Value is greater than Eagle Pharmaceuticals, Inc. (16.86M), greater than ANI Pharmaceuticals, Inc. (1.25B), greater than Phibro Animal Health Corporation (1.36B), greater than Deciphera Pharmaceuticals, Inc. (2.15B), less than Prestige Consumer Healthcare Inc. (4.73B), greater than Pacira BioSciences, Inc. (1.16B), greater than Collegium Pharmaceutical, Inc. (1.44B), greater than Procaps Group S.A. (473.19M), greater than Silver Spike Investment Corp. (33.56M), less than Alkermes plc (4.19B), less than Intra-Cellular Therapies, Inc. (8.69B), greater than Ironwood Pharmaceuticals, Inc. (1.20B), greater than Regencell Bioscience Holdings Limited (102.76M),
Company | Enterprise Value | Market cap |
---|---|---|
16.86M | $9.72M | |
1.25B | $1.18B | |
1.36B | $906.07M | |
2.15B | $2.21B | |
4.73B | $3.66B | |
1.16B | $758.79M | |
1.44B | $1.05B | |
473.19M | $200.83M | |
33.56M | $66.72M | |
4.19B | $4.30B | |
8.69B | $9.14B | |
1.20B | $669.31M | |
102.76M | $105.66M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HUTCHMED (China) Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like HUTCHMED (China) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is HUTCHMED (China) Limited's Enterprise Value?
What is the highest Enterprise Value for HUTCHMED (China) Limited (HCM)?
What is the 3-year average Enterprise Value for HUTCHMED (China) Limited (HCM)?
What is the 5-year average Enterprise Value for HUTCHMED (China) Limited (HCM)?
How does the current Enterprise Value for HUTCHMED (China) Limited (HCM) compare to its historical average?